Skip to main content
. 2016 Sep 21;22:3340–3351. doi: 10.12659/MSM.896927

Table 3.

LncRNA expression, symptomatology scores and total score before and after the antipsychotic treatment in schizophrenia patients.

Item Baseline (n=30) After treatment (n=30) t P
NONHSAT089447 (ΔCT) 3.23±4.26 5.13±3.51 −4.577 <0.001
NONHSAT021545 (ΔCT) 3.67±4.12 4.04±4.55 −0.858 0.398
NONHSAT041499 (ΔCT) 4.56±3.92 6.77±3.13 −5.056 <0.001
Positive subscale 19.94±5.98 9.32±4.78 8.993 <0.001
Negative subscale 21.29±8.24 10.58±4.56 8.778 <0.001
General psychopathology subscale 40.90±10.85 19.71±5.05 11.29 <0.001
Total score 81.84±18.13 39.61±7.64 13.80 <0.001
Lack of response 10.10±4.57 6.00±2.42 5.507 <0.001
Disturbance of thought 12.42±3.97 5.64±2.59 9.455 <0.001
Activity 5.84±2.19 3.29±2.12 7.289 <0.001
Paranoid 7.16±2.78 3.58±1.03 7.271 <0.001
Depression 10.68±3.30 5.74±2.62 8.093 <0.001
Aggressiveness 13.03±3.73 7.07±2.02 9.276 <0.001